Artikel ; Online: Design of a potential Sema4A-based multi-epitope vaccine to combat triple-negative breast cancer: an immunoinformatic approach.
Medical oncology (Northwood, London, England)
2023 Band 40, Heft 3, Seite(n) 105
Abstract: Immunotherapy is revamping the therapeutic strategies for TNBC owing to its higher mutational burden and tumour-associated antigens. One of the most intriguing developments in cancer immunotherapy is the focus on peptide-based cancer vaccines. Thus, the ... ...
Abstract | Immunotherapy is revamping the therapeutic strategies for TNBC owing to its higher mutational burden and tumour-associated antigens. One of the most intriguing developments in cancer immunotherapy is the focus on peptide-based cancer vaccines. Thus, the current work aims to develop an efficient peptide-based vaccine against TNBC that targets Sema4A, which has recently been identified as a major regulator of TNBC progression. Initially, the antigenic peptides derived from Sema4A were determined and evaluated based on their capability to provoke immunological responses. The assessed epitopes were then linked with a suitable adjuvant (RpfB and RpfE) and appropriate linkers (AAY, GPGPG, KK and EAAAK) to preclude junctional immunogenicity. Eventually, docking and dynamics simulations are performed against TLR-2, TLR-4, TLR-7 and TLR-9 to assess the interaction between the vaccine construct and TLR receptors, as the TLR signalling pathway is critical in the host immune response. The developed vaccine was then exposed to in silico cloning and immune simulation analysis. The findings suggest that the designed vaccine could potentially evoke significant humoral and cellular immune responses in the intended organism. Considering these outcomes, the final multi-epitope vaccine could be employed to serve as an effective choice for TNBC management and may open new avenues for further studies. |
---|---|
Mesh-Begriff(e) | Humans ; Triple Negative Breast Neoplasms/therapy ; Epitopes, T-Lymphocyte/chemistry ; Computer Simulation ; Vaccines, Subunit/chemistry ; Peptides ; Molecular Docking Simulation ; Computational Biology ; Epitopes, B-Lymphocyte/chemistry ; Semaphorins |
Chemische Substanzen | Epitopes, T-Lymphocyte ; Vaccines, Subunit ; Peptides ; Epitopes, B-Lymphocyte ; SEMA4A protein, human ; Semaphorins |
Sprache | Englisch |
Erscheinungsdatum | 2023-02-23 |
Erscheinungsland | United States |
Dokumenttyp | Journal Article |
ZDB-ID | 1201189-7 |
ISSN | 1559-131X ; 0736-0118 ; 1357-0560 |
ISSN (online) | 1559-131X |
ISSN | 0736-0118 ; 1357-0560 |
DOI | 10.1007/s12032-023-01970-6 |
Datenquelle | MEDical Literature Analysis and Retrieval System OnLINE |
Volltext online
Zusatzmaterialien
Kategorien
Verfügbar in ZB MED Köln/Königswinter
Zs.A 1899: Hefte anzeigen | Standort: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
Über subito bestellen
Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.